(Q44672184)

English

Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

author name string

Svetlana Semenova

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Athina Markou

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1249-1264

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Conversions from clozapine to other antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

A dopamine D1 agonist elevates self-stimulation thresholds: comparison to other dopamine-selective drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Differentiation of haloperidol and clozapine using a complex operant schedule in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

A neurobiological basis for substance abuse comorbidity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Dopaminergic mechanisms in the locomotor stimulant effects of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Cigarette smoking and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Dramatic decreases in brain reward function during nicotine withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Cigarette smoking: implications for psychiatric illness

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Clozapine as a drug of dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Clonidine modulates dopamine cell firing in rat ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens, and striatal microdialysis in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Symptoms of tobacco withdrawal. A replication and extension.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Neurobiology of the nicotine withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Enhanced lateral hypothalamic self-stimulation responding after chronic exposure to amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Long-term treatment with haloperidol or clozapine does not affect dopamine D4 receptors in rat frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Amphetamine and the reward system: Evidence for tolerance and post-drug depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Effects of chronic amphetamine or reserpine on self-stimulation responding: animal model of depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Rodent model of nicotine abstinence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Genetic predictors of therapeutic response to clozapine: current status of research

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

The effect of operant and electrode placement on self-stimulation train duration response functions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Clozapine decreases smoking in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Smoking and therapeutic response to clozapine in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Clozapine potently stimulates mesocortical dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Effects of acute and chronic treatment with clozapine on dopamine release in rat nucleus accumbens slice preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Putting the 'A' in atypical: does α2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Decreased brain reward produced by ethanol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: Evidence for mesolimbic supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Effects of antipsychotic drugs on brain-stimulation detection: Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Blockade of intracranial self-stimulation by antipsychotic drugs: Failure to correlate with central alpha-noradrenergic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900240-3

7 January 2021

Identifiers

10.1016/S0006-3223(03)00240-3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44672184&oldid=2031291757"